HESKA Feline UltraNasal FVRCP Vaccine (Canada)

This page contains information on HESKA Feline UltraNasal FVRCP Vaccine for veterinary use.
The information provided typically includes the following:
  • HESKA Feline UltraNasal FVRCP Vaccine Indications
  • Warnings and cautions for HESKA Feline UltraNasal FVRCP Vaccine
  • Direction and dosage information for HESKA Feline UltraNasal FVRCP Vaccine

HESKA Feline UltraNasal FVRCP Vaccine

This treatment applies to the following species:
Manufacturer: Heska

Feline Rhinotracheitis-Calici-Panleukopenia Vaccine

Modified Live Virus, Code 16D1.22

For Use in Cats and Kittens Only

Non-Injectable Vaccines

Description and General Information: Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, MLV is designed for nasal administration. Each of the viruses are widespread and is a common disease causing agent of cats.

HESKA Feline UltraNasal FVRCP Vaccine Indications

Recommended for the vaccination of healthy cats and kittens at least 12 weeks of age for the prevention of disease due to feline herpesvirus-1 (the cause of feline rhinotracheitis) and as an aid in the prevention of disease due to feline calicivirus and feline parvovirus (the cause of feline panleukopenia). Cats can be vaccinated with a single dose at 12 weeks of age. If cats are vaccinated at less than 12 weeks of age, a second vaccination should be administered at 12 - 16 weeks of age. Annual revaccination is recommended.

Precautions

Store out of direct sunlight at a temperature between 2° C-7° C (35° F-45° F). Use the entire contents of the vaccine when first opened. Do not vaccinate pregnant animals. Do not use in kittens younger than 4 weeks of age. Burn containers and all unused contents.

In rare instances, reactions can occur due to unusual sensitivity following use of this product. In such cases, administer epinephrine as an antidote. The vaccine will not protect against disease in the face of incubating feline herpesvirus, feline calicivirus or feline parvovirus infection. Therefore, only healthy cats should be considered as candidates for vaccination.

Transient sneezing for one or more days after vaccination is not uncommon. A small number of cats may experience other mild post-vaccination side effects including ocular and/or nasal discharge, GI signs (such as vomiting) or, in rare instances, nasal or oral ulcers. A transient slight drop in the white blood cell count has been noted at times after vaccination. These signs are usually mild and clear without treatment.

Contains gentamicin and fungistat as preservatives.

Dosage and Administration

Administer a single 0.2 ml dose intranasally, divided into both nostrils. NOTE: Use a new dropper for each cat vaccinated. No needles are necessary to administer the vaccine. This vaccine is NOT intended for intramuscular or subcutaneous injection.

STEP 1:

Remove the cap and rubber stopper from one vial of liquid vaccine and one vial of lyophilized vaccine.

STEP 2:

Using the nasal dropper, transfer the liquid vaccine (0.2 ml) to the lyophilized vaccine vial.

STEP 3:

Mix the vaccine in the vial with a gentle swirling motion.

STEP 4:

Once dissolved, immediately withdraw the rehydrated vaccine into the nasal dropper.

STEP 5:

Vaccinate the cat by placing the vaccine equally in each nostril. Avoid touching the nose with the dropper.

Keep refrigerated at a temperature between 2° C-7° C (35° F and 45° F). Store out of direct sunlight.

Heska Corporation, 1-800-GO HESKA Loveland, Colorado 80538

U.S. Vet. License No. 213

©2007 Heska Corporation. All Rights Reserved.

HESKA and Feline UltraNasal are registered trademarks of Heska Corporation in the U.S. and/or other countries.

20 DOSES

Contains 20 (1 dose) vials of dry vaccine, 20 (0.2 ml) vials of liquid vaccine and 20 droppers.

04205

904105

NAC No.: 15550001

HESKA CORPORATION
Distributed by AVENTIX ANIMAL HEALTH CORP.
4350 MAINWAY, BURLINGTON, ON, L7L 5R7
Telephone:   905-332-4744
Toll-Free:   877-909-2242
Fax:   905-332-4844
Website:   www.aventix.ca
Email:   aventix@aventix.ca
Every effort has been made to ensure the accuracy of the HESKA Feline UltraNasal FVRCP Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web3)